GlassScriptPhysician profile
Jennifer R Shaffer
NPI 1831358597
$8,139.99
in general payments reported to CMS, 2019-2025
23 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.29 · 2020: $47.95 · 2022: $336 · 2023: $7,277 · 2024: $265 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,000 · Travel and Lodging: $991 · Food and Beverage: $736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,000.00 |
| Travel and Lodging | $991.09 |
| Food and Beverage | $736.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,008.08 | 2023 | Da Vinci Surgical System, Ion |
| Astrazeneca Pharmaceuticals LP | $216.00 | 2022-2025 | Fasenra, Tezspire, Breztri |
| Ethicon INC. | $188.13 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.63 | 2019-2023 | Ofev |
| Glaxosmithkline, LLC. | $93.32 | 2022-2025 | Nucala, Trelegy Ellipta |
| Ucb, INC. | $54.32 | 2024 | Nayzilam |
| Regeneron Healthcare Solutions, INC. | $53.47 | 2023-2024 | Dupixent |
| Philips North America LLC | $51.66 | 2022-2025 | Vest Therapy Und |
| Genentech USA, INC. | $47.95 | 2020 | |
| Insmed, INC. | $35.26 | 2024-2025 | Arikayce, Brinsupri |
| Novartis Pharmaceuticals Corporation | $34.29 | 2023-2024 | |
| Amgen INC. | $28.42 | 2025 | Tavneos |
| Takeda Pharmaceuticals U.S.A., INC. | $26.88 | 2024 | Glassia |
| Grifols USA, LLC | $25.88 | 2025 | Prolastin-C Liquid |
| Abiomed | $25.47 | 2023 | Impella |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $24.85 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $22.88 | 2022 | |
| United Therapeutics Corporation | $18.96 | 2025 | Tyvaso |
| Electromed, INC. | $17.83 | 2025 | Smartvest |
| Inogen, INC. | $17.68 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Genzyme Corporation | $17.39 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.35 | 2023 | |
| Shionogi INC | $17.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Shaffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.